Colombia: Ramping up the Local Footprint
With Latin America’s best healthcare system in terms of both coverage and quality, Colombia is fast becoming a…
AMERICAS
The NFL’s Opioid Crisis: Is Cannabis the Answer?
With an increasing number of NFL players relying on potentially dangerous prescription painkillers, does the league…
Leading a patients alliance
David Peña Castillo is the President and founder of The Mexican Federation of Rare Diseases (FEMEXER). Here he…
Brazilian Pharma: An Industry on a High
“Brazil undoubtedly holds great development opportunities for the global pharmaceutical and healthcare…
Investing in Canadian Health: We Know the Cost, but Can We Talk About Value?
As the President of Innovative Medicines Canada, Pamela Fralick leads the industry association for Canada’s…
New Drugs Approved in Canada 2018
In total there were 27 new active substances (NASs) approved in Canada in 2018, 18 prescription pharmaceutical…
“Canada Needs to do Better in Supporting Innovative Biopharma”
Brian Hilberdink, President of Novo Nordisk Canada, calls for the Canadian government to encourage and invest in…
Canada Medtech Facts & Figures Snapshot
Canadian medtech at a glance: market value, number of companies, number of employees,export markets, spinoffs.…
Mexico Facts and Figures Snapshot
This chart gives an insight into the phenomenal importance of the pharmaceutical industry to Mexico, in terms of…
